The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: A study on Chinese Han population

Experimental Dermatology

Volumn 17, Issue 12, 2008, Pages 1059-1062

  Guan, Cui Ping ^a   Zhou, Miao Ni ^a   Xu, Ai E ^a   Kang, Ke Fei ^b   Liu, Ji Feng ^a   Wei, Xiao Dong ^a   Li, Yong Wei ^a   Zhao, De Kuang ^a   Hong, Wei Song ^a  

^a THE THIRD PEOPLE S HOSPITAL OF HANGZHOU   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nrf2 gene; Polymorphism; Vitiligo

Indexed keywords

TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; TANDEM REPEAT; VITILIGO;

ADOLESCENT; ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; TANDEM REPEAT SEQUENCES; VITILIGO; YOUNG ADULT;

EID: 56349163056     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00752.x     Document Type: Article

References (28)

1. Le Poole I C, Sarangarajan R, Zhao Y, et al. "VIT-1", a novel gene associated with vitiligo. Pigment Cell Res 2001: 14: 475-484.
2. Kim H J, Choi C P, Uhm Y K, et al. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population. Exp Dermatol 2007: 16: 561-566.
3. Koca R, Armutcu F, Altinyazar H C, Gurel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004: 29: 406-409.
4. Agrawal D, Shajil E M, Mafratia Y S, Begum R. Study on the antioxidant status of vitiligo patients of different age in Baroda. Pigment Cell Res 2004: 179: 289-294.
5. Hazneci E, Karabulut A B, Ozturk C, et al. A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 2005: 44: 636-640.
6. Ines D, Sonia B, Riadh B M, et al. A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res 2006: 298: 147-152.
7. Kobayashi A, Ohta T, Yamamoto M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 2004: 378: 273-286.
8. Jaiswal A K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004: 36: 1199-1207.
9. Itoh K, Tong K I, Yamamoto M. Molecular mechanism activating nrf2-keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 2004: 36: 1208-1213.
10. Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000: 275: 16023-16029.
11. Cho H Y, Jedlicka A E, Reddy S P, Zhang L Y, Kensler T W, Kleeberger S R. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol 2002: 26: 42-51.
12. Cho H Y, Jedlicka A E, Reddy S P, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002: 26: 175-182.
13. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999: 13: 76-86.
14. Stewart D, Killeen E, Naquin R, Alam S, Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem 2003: 287: 2396-2402.
15. Nguyen T, Sherratt P J, Huang H C, Yang C S, Pickett C B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 2003: 287: 4536-4541.
16. McMahon M, Itoh K, Yamamoto M, Hayes J D. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003: 278: 21592-21600.
17. Itoh K, Wakabayashi N, Katoh Y, Ishii T, O-Connor T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003: 8: 379-391.
18. Yamamoto T, Yoh K, Kobayashi A, et al. Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem Biophys Res Commun 2004: 321: 72-79.
19. Marzec J M, Christie J D, Reddy S P, et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007: 21: 2237-2246.
20. Terwilliger J D, Ott J Linkage disequilibrium between alleles at marker loci. In: Handbook of Human Genetic Linkage, 1st edn. Eds: Terwilliger J D, Ott J. Baltimore: Johns Hopkins University Press, 1994: 188-198.
21. Schallreuter K U, Wood J M, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991: 97: 1081-1085.
22. Schallreuter K U, Moore J, Wood J M, et al. Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 2001: 116: 167-174.
23. Schallreuter K U, Moore J, Wood J M, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999: 4: 91-96.
24. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997: 109: 310-313.
25. Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994: 7: 110-111.
26. Beazley W D, Gaze D, Panske A, Panzig E, Schallreuter K U. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999: 141: 301-303.
27. Park H H, Ha E, Uhm Y K, et al. Association study between catalase polymorphisms and susceptibility to vitiligo in Korean population. Exp Dermatol 2006: 15: 377-380.
28. Uhm Y K, Yoon S H, Kang I J, Chung J H, Yim S V, Lee M H. Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population. Life Sci 2007: 81: 223-227.